034940 — ChoA Pharmaceutical Co Balance Sheet
0.000.00%
- KR₩31bn
- KR₩54bn
- KR₩63bn
- 12
- 46
- 18
- 11
Annual balance sheet for ChoA Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 9,065 | 10,214 | 6,996 | 4,415 | 5,472 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 25,054 | 24,932 | 27,623 | 23,908 | 20,971 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 47,350 | 46,504 | 48,200 | 42,157 | 39,740 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 22,190 | 24,074 | 24,999 | 20,370 | 19,712 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 82,377 | 80,512 | 85,639 | 74,221 | 71,320 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 19,178 | 24,263 | 27,328 | 29,178 | 36,656 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 24,075 | 30,592 | 32,796 | 33,228 | 39,944 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 58,302 | 49,920 | 52,844 | 40,993 | 31,376 |
| Total Liabilities & Shareholders' Equity | 82,377 | 80,512 | 85,639 | 74,221 | 71,320 |
| Total Common Shares Outstanding |